AlphaCore Capital Portfolio holdings
Top Buys
| 1 |
Vanguard Large-Cap ETF
VV
|
+$51.1M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$14.6M |
| 3 |
Vanguard Value ETF
VTV
|
+$13.9M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$13.4M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$10.7M |
Top Sells
| 1 |
ImmunityBio
IBRX
|
+$20.4M |
| 2 |
iShares US Financials ETF
IYF
|
+$17M |
| 3 |
iShares US Consumer Discretionary ETF
IYC
|
+$16.8M |
| 4 |
Vanguard Growth ETF
VUG
|
+$16.4M |
| 5 |
CDTX
Cidara Therapeutics
CDTX
|
+$14.8M |
Sector Composition
| 1 | Technology | 6.67% |
| 2 | Energy | 4.51% |
| 3 | Communication Services | 3.81% |
| 4 | Financials | 3.41% |
| 5 | Healthcare | 2.14% |
Similar funds
AlphaCore Capital's Q1 2026 Portfolio in Review
As of Q1 2026, AlphaCore Capital held 1,540 positions worth $4.22B, down 5.9% from $4.48B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
AlphaCore Capital withdrew a net $258M in Q1 2026, closing 339 positions and reducing 581 holdings. Its most notable exit was Cidara Therapeutics, an estimated $14.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 6.7% of assets, down from 7.5% a quarter earlier, followed by Energy and Communication Services.
Against the trend, AlphaCore Capital opened a new position in American Beacon GLG Natural Resources ETF worth $5.59M.
- AlphaCore Capital's largest Q1 2026 buy was American Beacon GLG Natural Resources ETF: 108,404 shares worth $5.59M.
- AlphaCore Capital added most to Vanguard Large-Cap ETF in Q1 2026, an estimated $51.1M increase.
- AlphaCore Capital's biggest Q1 2026 reduction was ImmunityBio, cutting an estimated $20.4M.
- AlphaCore Capital fully exited Cidara Therapeutics in Q1 2026, selling an estimated $14.8M.
- AlphaCore Capital's ten largest holdings make up 23% of its $4.22B portfolio in Q1 2026.
- AlphaCore Capital opened 118 new positions and closed 339 in Q1 2026.
- AlphaCore Capital's portfolio value fell 5.9% quarter-over-quarter to $4.22B.
Based on AlphaCore Capital's 13F filing for Q1 2026, filed 15 May 2026.